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Abstract: Effective and efficient management of human betacoronavirus severe acute respiratory 
syndrome (SARS)-CoV-2 infection i.e., COVID-19 pandemic, required sensitive sensors with short 
sample-to-result durations for performing diagnostics. In this direction, one of appropriate alternative 
approach to detect SARS-CoV-2 at low level (fmol) is exploring plasmonic metasensor technology for 
COVID-19 diagnostics, which offers exquisite opportunities in advanced healthcare programs, and modern 
clinical diagnostics. The intrinsic merits of plasmonic metasensors stem from their capability to squeeze 
electromagnetic fields, simultaneously in frequency, time, and space. However, the detection of low-
molecular weight biomolecules at low densities is a typical drawback of conventional metasensors that has 
recently been addressed using toroidal metasurface technology. This research reports fabrication of a 
miniaturized plasmonic immunosensor based on toroidal electrodynamics concept that can sustain robustly 
confined plasmonic modes with ultranarrow lineshapes in the terahertz (THz) frequencies. By exciting 
toroidal dipole mode using our quasi-infinite metasurface and a judiciously optimized protocol based on 
functionalized gold nanoparticles (NPs) conjugated with the specific monoclonal antibody of SARS-CoV-
2 onto the metasurface, the resonance shifts for diverse concentrations of the spike protein is monitored. 
Possessing molecular weight around ~76 kDa allowed us to detect the presence of spike protein with 
significantly low LoD ~4.2 fmol.  
 
Keywords: SARS-CoV-2 spike protein; COVID-19 pandemic; terahertz plasmonic biosensors, toroidal 
metasurfaces, femtomole-level detection. 
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Pioneering efforts in developing reliable and timely recognition of infectious virus using standard methods 
date back to the end of the previous century, when intermittent wide-spread epidemics from emerging 
viruses, such as HIV, severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome 
coronaviruses (MERS), pandemic influenza H1N1, Ebola and Zika, now SARS-CoV-2 associated 
respiratory syndrome i.e., COVID-19,[1-3] occurred.[1-6] Studies have shown that most of these epidemics 
derived from the zoonotic animal-to-human transmission incidents.[7,8] In spite of continuous advancements 
in the development of novel diagnostic approaches in recent years, on every occasion, dramatic scarcities 
in rapid and accurate detection of infections have hindered the public health response to the evolving 
epidemiological threat. Considering COVID‐19 pandemic,[1-3,7,8] there have been unceasing efforts to 
develop sensitive and selective recognition modalities using both standard and innovative approaches 
needed for timely diagnostics of COVID-19. CRISPR–Cas12-based detection,[3] quantitative real‐time 
polymerase chain reaction (RT-PCR),[9,10] ELISA (the enzyme-linked immunosorbent assay),[11] point‐of‐
care (POC) lateral flow immunoassay test,[12,13] CT-imaging,[14] and some hematology parameters are the 
primary focus for clinical diagnosis of the recent fatal virus. Although the accomplished progress in such a 
short duration is promising, most of these techniques are subject to common limitations.[15] Firstly, many 
of the available techniques have long turnaround times and they are very slow. Secondly, for example, the 
RT-PCR tests require certified facilities, sophisticated equipment equipped laboratories, and well-trained 
personal. Thirdly, in many cases, they suffer from the poor sensitivity where a detection of virus is 
recommended at picomolar (pM). Finally, testing of specific antibodies against SARS‐CoV‐2 in collected 
patient’s or recovered individual’s blood is an invasive approach for the assessment of the disease. Instead, 
saliva test has just been recommended as a decisive and non-invasive sensing procedure at the very early-
stages of the virus,[16,17] which possesses immense potential to be utilized in optical sensors and analogous 
non-contact devices. Recently, several nanoscale integrated architectures based on optical and electronic 
systems have been introduced to detect SARS-CoV-2 spike protein with much higher sensitivity, such as 
photothermal biosensors using gold nanoparticles (NPs) aggregates[18,19] and gated graphene-enhanced 
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field-effect transistor (FET)-based biosensor.[20] Generally, most of these devices have assisted reasonably 
sensitive detection of SARS-CoV-2 virus, in subsequent biological components, needed for COVID-19 
diagnostics as a major component of pandemic management. However, there is a continuous demand for 
on-chip, label-free, selective, repeatable, cost-effective, ready-to-use, and ultrasensitive biosensors. 
Focusing on photonics architectures, among diverse types of optical biosensors, plasmonic devices 
based on quasi-infinite metasurfaces are promising tools that have facilitated precise screening and 
recognition of diverse biomarkers through substantial field confinement at subwavelength geometries.[21,22] 
This intriguing feature allowed detection of targeted biomolecules in highly diluted solutions at low 
concentrations.[21-24] As a cornerstone of photonics, artificially engineered plasmonic metasurfaces have 
stimulated the development of efficient, label-free, non-contact, non-invasive, and non-poisonous, multi-
analyte immunosensing tools, devised for rapid and real-time detection of the fingerprints of diverse 
infections and viruses,[25-27] which are particularly important for the diagnosis of diseases and routine point-
of-care (POC) clinical evaluations. Their remarkable advantages aside, most of the presently available 
optical biosensing and immunosensing methods dramatically suffer from poor limit of detection (LoD) and 
moderate precision in the identification of ultralow-weight biomolecules at lower densities.[28] 
Most of these drawbacks have recently been addressed using the concept of toroidal metasensor based 
on flatland plasmonic structures.[30-35] It is shown that these platforms are operating based on the third family 
of resonant modes, known as toroidal multipoles.[36,37] The observation and study of these resonant moments 
in static form was reported in the middle of the previous century,[38] which was primarily established based 
on the physics of elementary particles. Later, the toroidal electrodynamic framework was described based 
on classical electromagnetism,[39] and subsequently the excitation of strong dipolar modes was realized in 
three-dimensional (3D) artificial media across the microwave frequencies.[40,41] Driven by the ongoing race 
to miniaturization, researchers are now able to fabricate toroidal-resonant metadevices in exquisite 
architectures to function at much longer frequencies).[42-45] For example, in the THz regime, a common 
feature of toroidal metasensors is the ability of focusing the incident electromagnetic radiation within a tiny 
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spot. Additionally, by considering the Eq. 2 in Ref. [29], these metamolecules support resonances that 
possess much higher sensitivity to the refractive index perturbations in the surrounding media. To capitalize 
on these proof-of-principle developments, newly, practical and accurate screening of envelope proteins of 
a specific virus (Zika virus envelope protein with the molecular weight of ~13 kDa) and antibiotic molecules 
(kanamycin sulfate or Kantrex, C18H36N4O11 × H2SO4, with the molecular weight of ~600 Da) have been 
reported based on this metasensor technology.[31,33-35] Though the detection of biomolecules with molecular 
weight less than <600 Da was testified based on bulky 3D metamaterials (e.g. hyperbolic metamaterials) at 
pM densities,[46] similar performance has never been experienced using conventional structures based on 
flatland meta-optics. The low molecular weight of these biomolecules distinctively clarifies the superior 
performance of these sensors compared to analogous planar metasystems in all range of frequencies. This 
also verifies that the proposed THz toroidal metasensors are qualified candidates for the detection of much 
heavier hormones and drugs, organisms, enzymes, and envelope proteins at very low concentrations. 
In this Letter, to resolve the inherent drawbacks of COVID-19 diagnosis tools via detecting SARS-
CoV-2 spike protein, we developed a THz plasmonic biosensor device based on toroidal dipole-resonant 
metamolecules that demonstrates extreme sensitivity to the presence of SARS‐CoV‐2 spike protein. 
Toroidal dipole-resonant metasurfaces exhibit unconventional spectral properties that feature low-radiative 
losses, low mode volumes, and ultranarrow spectral lineshapes through robust confinement of 
electromagnetic fields. Using these distinct advantages, we tailored a symmetric multipixel planar 
metamolecule to support a pronounced toroidal dipole at the sub-THz spectra (~0.4 THz). To improve the 
binding properties of the targeted biomolecules to the devised metasurface, we introduced functionalized 
colloidal gold NPs conjugated with the respective antibody and captured the spike proteins present in the 
sample. Since the proposed configuration is a quasi-infinite platform based on periodic arrays of resonant 
unit cells, the practical realization of a miniaturized, multiplexed, and on-chip immunobiosensing 
instrument is possible for a wide range of applications (e.g. POC). Ultimately, we evaluated the 
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performance of the sensor device in highly diluted solutions and showed that the implemented tool provides 
femtomolar (fM)-level detection of SARS-CoV-2 spike proteins. 
Developed protocol to functionalize gold NPs. A schematic of conducted research workflow is depicted 
in Figure 1a. Synthesized surface-functionalized gold NPs colloids, with the average diameter of ~45 nm 
(see Figure S1 in Supplementary Information), were utilized with robust covalent conjugation to primary 
amines (-NH2) of proteins. For the conjugation of SARS-CoV-2 (2019-nCoV, Rabbit MAb) Spike S1 
antibody (Sino Biological Inc.) with the NHS activated gold NPs (1 mL), a reconstitution buffer was 
prepared by combining 0.1 M of reactant buffer with 50 µL of purified antibody. Right after the addition 
of buffer, the gold NP conjugate was and sonicated for 45 seconds. The solution is incubated while rotating 
at room temperature for 30 minutes. Next, 10 μL of quencher was added to deactivate any remaining active 
NHS-esters. The solution is centrifuged at 5700 rpm for 10 min (at 4 °C). Then, the supernatant is removed 
cautiously and resuspended with 0.1 mL of reaction buffer. By reiterating the centrifuging process with the 
same protocol, eventually, conjugate diluent (50 μL) was added and sonicated. The transmission electron 
microscopy (TEM) image of the functionalized gold NPs bounded with the respective antibody is depicted 
in Figure 1b. To prepare the gold NPs with specific antibodies [SARS-CoV-2 (2019-nCoV) Spike S1-His 
recombinant protein (Sino Biological Inc.)], we used both lyophilized 99% bovine serum albumin (BSA) 
(Sigma-Aldrich) and pH~7.4 phosphate buffer solution (PBS) to dissolve the immunoreagents. For real-
time characterization, after washing the chips with PBS, antibody-modified structures were incubated in 
PBS containing 0.1 wt. % BSA for 30 min. Next, different concentrations of SARS-CoV-2 recombinant 
 
Figure 1. Functionalization of colloidal gold NPs. a, A schematic for the workflow of the developed functionalized gold 
NPs conjugated with the respective SARS-CoV-2 antibody and spike proteins. b, A TEM image of gold NPs conjugated with 
the respective antibody of SARS-CoV-2. 
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spike protein ranging from 2 fmol to 50 fmol in PBS was prepared using serial dilution. Once ready, the 
antibody-functionalized microstructures were rinsed and stored at 4 °C. An optimized time of 20 mins was 
used for the immucomplex formation at the miniaturized toroidal sensor metasurface. Figure 1a also 
contains an artistic picture of the functionalized gold NPs conjugated with the antibody and its subsequent 
binding with spike protein of SARS-CoV-2. 
Spectral response of THz metasurface. Figure 2a shows the schematic representation of the deigned 
toroidal THz metamolecule (not to scale), adopted from our previous work in Ref. [33], where 
functionalized gold NPs are dispersed onto the surface of the platform to improve the binding of 
 
Figure 2. Simulation, fabrication, and characterization of toroidal THz plasmonic metasurface. a, An artistic rendering 
of the designed multipixel toroidal unit cell, including the dispersed functionalized gold NPs on top. The polarization direction 
of the incidence is demonstrated inside the panel. b, Numerically calculated (solid) and experimentally probed (dot) 
transmission spectra of the toroidal metasurface under transverse polarized THz light. The inset is the SEM image of the 
fabricated metasurface. Scale bar: 100 µm. e, Theoretically calculated scattered power from individual electromagnetic 
multipoles induced in the spectral response of metasurface. p: electric dipole, m: magnetic dipole, Q(e): electric quadrupole, 
Q(m): magnetic quadrupole, T: toroidal dipole. 
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biomolecules to the metasurface. The geometries of the unit cell are specified in the Supplementary 
Information (Figure S2). The numerically and experimentally studied transmission spectra (normalized) of 
the metasurface in the absence of gold NPs are plotted in Figure 2b. The spectra were obtained through the 
judicious geometric tuning of the unit cell under transverse-electric (TE) polarized illumination (s-polarized 
beam) to support a distinct toroidal dipole at the sub-THz spectra, around ~0.4 THz. Besides, this profile 
contains a second minimum around ~0.6 THz correlating with the magnetic dipole mode, which is not 
related to the scope of this study. The scanning electron microscope (SEM) image of the fabricated planar 
metasurface is shown in the inset of Figure 2b, which comprises periodic arrays of engineered gold 
metamolecules (details on numerical and experimental steps are explained in Supplementary Information). 
Considering the excitation principle of a toroidal dipole in planar metasurfaces,[47-49] we theoretically 
verified the formation of this mode via vectorial surface current density map to exhibit the required 
discrepancy between the direction of induced magnetic moments in proximal resonators. In particular, a 
destructive interference between these oppositely pointed magnetic moments in adjacent resonators leads 
to the formation of a head-to-tail configuration consisting of a confined arrangement of both charges and 
currents, which results in the projection of a dynamic toroidal dipole from the scatterer (Figure S3, 
Supplementary Information). To provide a full understanding of the induction of toroidal dipole resonance, 
 
Figure 3. E-field confinement in the toroidal metamolecule. a, Cross-cut electric field enhancement (|E|2) as a function of 
position along x-axis, simulated for a unit cell at the toroidal dipole frequency, showing significant intensity of the confined 
fields at the capacitive openings in each resonator. b, 3D E-field enhancement map at the frequency of toroidal dipole, in which 
the strong field confinement was spotted at capacitive gap regions. The polarization and incident light direction are indicated 
inside the panel. 
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we further analyzed the multipole decomposition of an arbitrary vector field by considering the radiated 
power from electric, magnetic, and toroidal multipoles  (Figure 2c).[50] Noticing here, the toroidal dipole 
extreme is dominant contributor to the metasurface response, while the other dipolar and multipolar 
electromagnetic modes are suppressed. 
Another key parameter of the resonant metasurfaces is the confinement of electromagnetic fields by 
the structured metamolecule. As previously discussed, the ultratight field confinement of toroidal 
metastructures is a unique feature that enables high sensitivity to the environmental perturbations, 
analogous to localized surface plasmons-based bio(chemical) sensors.[51,52] Figure 3a illustrates a cross-cut 
profile of electric-field (E-field) enhancement as a function of a unit cell length along the x-axis, showing 
a substantial field confinement at the capacitive gap regions in both resonators (see the highlighted regions 
in the panel). Beyond that, we calculated the 3D E-field enhancement map across the unit cell at the toroidal 
dipole frequency, validating the strong confinement of plasmons at the capacitive openings (Figure 3b). 
These locally generated energetic areas are related to the highlighted regions in the cross-sectional E-field 
enhancement map in Figure 3a. 
Detection of SARS-CoV-2 Spike Protein. In continue, to highlight the important role toroidal radiations 
can play in the detection of targeted biomolecules, it is of value to define its behavior to the presence of 
SARS-CoV-2 spike proteins bounded to the metasurface, driven by an incident polarized beam. By putting 
our structured metasurface into practice through dispersing of the functionalized gold NPs onto its surface, 
we conducted a standard evaluation strategy to determine the analytic LoD and sensitivity of the device. To 
that end, we harnessed a protocol based on a combination of our previously utilized scenario for the 
diagnosis of Zika virus envelope proteins and screening of Kantrex biomolecules.[33,34] For the case of 
SARS-CoV-2 spike proteins, the assessment of these biomolecules surrounding the toroidal-resonant unit 
cell is executed by defining the difference between the transmission tensors in absence and presence of 
spike proteins. In this regime, we merely consider the tensors correlating with the transmitted and incident 
electric fields through the metasurface under s-polarized beam illumination (
10 
 
2 2
Antibody+PBS Spike protein( ) ( ) ( )yy yyT f T f T f   ).
[53] This model is built on the experimental evolution of the 
sensing approach. Using this mechanism, the transmission tensor due to SARS-CoV-2 spike proteins can 
be defined by subtracting following tensors: 1) the transmission tensors for the samples containing the 
respective antibody plus phosphate buffer solution (PBS), and 2) the same sample with the captured spike 
proteins. To this end, we initially determined the reference point for the proposed sensing technique by 
recording the transmission spectrum of the device by injecting PBS to the functionalized gold NPs 
conjugated with the relevant antibody. Later, we injected different concentrations of SARS-CoV-2 spike 
protein to the solution and measured the variations in the transmittance. 
As discussed above, as a control, we primarily prepared 15 µL solution including functionalized gold 
NPs conjugated with the SARS-CoV-2 antibody and PBS (without the spike protein), then probed the 
transmission spectra (Figure 4a, black line). Repeating the same scenario for the samples in the presence of 
spike proteins, one can characterize the variations in the position of the toroidal dipole. The transmission 
profile for different concentrations of spike proteins (from 4 fmol to 12 fmol) is presented in Figure 4a, 
where the gold NPs play the fundamental role of conjugation with antibody, capturing of proteins, and 
binding with the metamolecules. Here, we observed a traditional and slight red-shift in the position of 
dipolar mode owing to surface chemistry. On the other hand, by dispersing the spike protein onto the 
metasystem, we observed a significant red-shift in the toroidal dipole frequency (Figure 4a), where a 
frequency shift of 2.12 GHz was observed for 4 fmol of spike protein. Continuous increases in the 
concentration of SARS-CoV-2 spike protein leads to additional red-shifts in the position of the resonance, 
and for 12 fmol, the frequency shift was measured around 6.912 GHz. It is noteworthy to consider that 
before each introduction of a new concentration of biomolecules, PBS was injected into the samples to 
remove the unbound or weakly attached spike proteins. Moreover, sensor performance was monitored as a 
frequency shift by dispersing of gold NPs with different concentrations of spike proteins (from 14 fmol to 
20 fmol) onto the sensor surface. Nonlinear variation in the frequency shift (Figure 4b), as a function of the 
protein density, was observed, which allows to quantitatively determine the corresponding analytic LoD 
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for the sensor around ~4.2 fmol based on a 4 times the signal-to-noise ratio (SNR) criterion. Various 
densities of functionalized gold NPs, including captured spike proteins, ranging from 2 to 20 fmol, were 
dropped and dried on the surface of the devised metasurface in several steps. The demonstrated findings in 
Figure 4b indicates the connection between the toroidal dipole shift and the protein concentration, in which 
7.52 GHz shift in the position of the toroidal dipole was observed for 20 fmol of spike. 
Such displacements in the position of toroidal dipole mode when the protein concentration increased 
accompanies with slight decline in its quality-factor (Q-factor). The variations in the Q-factor and 
corresponding dephasing time (τd) due to the presence of spike proteins are demonstrated in Figure 4c. This 
panel illustrates the impact of the biomolecules in different condensation on the induced toroidal resonance 
lineshape and the corresponding dephasing time, because of the modified transmission tensor. Using the 
classical analysis for the calculation of radiative Q-factor, this component was defined as the ratio of the 
toroidal dipole frequency to the full width at the half maximum (δ) of the lineshape (Q=f0/δ). On the other 
hand, following equation is used to quantify dephasing time:[54,55] τd= 2ℏ/δ. In Figure 5c, we plotted the 
radiative Q-factor and dephasing time variations as a function of SARS-CoV-2 spike protein concentration. 
Though by increasing the concentration of biomolecules, the linewidth of the toroidal dipole continuously 
decays, the induced resonance rationally retains its quality at high concentrations. This implies that at the 
higher densities of biomolecules, the developed metasensor keeps its performance. 
 
Figure 4. Evaluation of metasensor performance using functionalized gold NPs and captured spike proteins. a, 
Measured transmission spectra of the THz metasensor device for different concentrations (4 fmol to 12 fmol) of SARS-CoV-
2 spike protein. For 0 fmol of spike protein, the spectral response was defined merely for antibody conjugated gold NPs plus 
PBS. b, Variations of the toroidal mode frequency shift for different concentrations of injected spike proteins captured by 
relevant antibody ranging from 2 fmol to 20 fmol. c, The Q-factor and dephasing time (τd) of the toroidal lineshape as a function 
of protein concentration. 
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Our findings by far raise the intriguing question: whether toroidal THz plasmonic immunobiosensor 
metasystem can be employed as a promising and precise tool to detect targeted biomolecules in highly 
diluted samples or not. To address this inquiry, and to qualitatively and qualitatively demonstrate the 
ultrahigh sensitivity of the implemented metasensor for the detection of spike proteins in extremely dilute 
solutions, we used a combination of biomolecules composed of high and low molecular weights. This 
includes targeted spike proteins plus BSA with molecular weights of ~76 kDa and ~66.5 kDa, respectively. 
Although the molecular weights of both biomolecules are close to each other, this allows to understand the 
influence of the heavy bio-objects on the sensing performance of the metadevice. Using the same protocol 
as we developed earlier in this study, we prepared colloidal gold NPs with different concentrations of BSA 
and spike protein. To carefully remove the unbounded and weakly conjugated/captured antibody and 
protein, as well as BSA molecules to the NPs, we thoroughly washed the samples before every experiment 
by distilled water. By introducing functionalized gold NPs solutions to the surface of the metastructure, we 
probed the transmission spectra as a function of BSA, spike protein, and spike protein + BSA at different 
concentrations (Figures 5a and 5b). Fixing the concentration of biomolecules in all assays between 2 fmol 
and 50 fmol, the acquired measurement results for the binding of BSA to colloidal gold NPs show the 
frequency shift owing to different concentrations of BSA. This is consistent with the observed nonlinear 
 
Figure 5. Evaluation of the THz metasensor in diluted solution. a, b, Measured transmission spectra of the THz metasensor 
device for different concentrations (from 4 fmol to 30 fmol) of BSA and SARS-CoV-2 spike protein + BSA, respectively. For 
0 fmol of spike protein, the spectral response was defined merely for antibody conjugated gold NPs plus PBS. c, Variations of 
the toroidal dipole mode for different concentrations of BSA, SARS-CoV-2 spike protein, and BSA+SARS-CoV-2 spike 
protein. The spike proteins in all experiments were captured by functionalized gold NPs conjugated with the respective 
antibody. 
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trend of the spike protein in Figure 4b. It should be underlined that direct measurement of the population 
of biomolecules on the metasurface is quite challenging, however, we can still define the impact of each 
biomolecule on the sensing performance quantitatively using the proposed methodology in Ref. [46]. By 
considering the shifts in the position of resonance for BSA biomolecules as 4.15 GHz and 6.19 GHz for 
spike protein at 10 fmol, this implies a mean shift per particle which can be approximated as 0.14 GHz and 
0.21 GHz, respectively. It should be noted that as the molecular weight of spike protein is almost 1.15 times 
bigger than BSA, the relatively higher sensitivity going from BSA to SARS-CoV-2 spike protein is 
significant. Our experimental analyses also revealed that the sensor performance is high at the lowest 
concentrations, and as can be seen in Figure 5c, the shift in the position of toroidal dipole reduces 
dramatically and saturates for further concentrations of biomolecules. Ultimately, we summarized and listed 
the important parameters and results for the offered metasensor in Table 1. This allows to quantitatively 
compare the performance of the toroidal metasensor with recently reported similar mechanisms [15,17] for 
the detection of SARS-CoV-2 spike proteins. 
 
Table 1. Important parameters and the obtained results from assays for the plasmonic metasensor. 
Sensor device 
Plasmonic metasensor 
[Current approach] 
Plasmonic 
photothermal 
biosensor [15] 
Gated graphene-
enhanced FET based 
biosensor [17] 
Target 
SARS-CoV-2 spike 
protein 
SARS-CoV-2 spike 
protein 
SARS-CoV-2 spike 
protein 
LoD ~4.2 fmol 0.22 pM 1 fg/mL 
Assay 
components 
Gold NPs, SARS CoV-2 
antibody 
Gold nanoparticles, 
SARS CoV-2 antibody 
Graphene sheet, SARS 
CoV-2 antibody 
Preparation & 
Assay reaction 
time (estimated) 
~50 min > 3 h N/A 
Assay sample-
to-result time 
(estimated) 
~80 min (including 
reaction time) 
> 5 h >48 h 
Assay Results 
Qualitative and 
Quantitative 
Quantitative Qualitative 
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Conclusion. In conclusion, we have developed a highly sensitive miniaturized THz toroidal plasmonic 
metasensor to detect SARS-CoV-2 spike protein at femtomole-level concentrations. Our results revealed 
that introducing functionalized gold NPs to the multipixel metallic metasurface substantially improves the 
binding strength of biomolecules and subsequently boosts the sensitivity of device. Taking advantage of 
rationally high Q-factor, ultratight field confinement, and high sensitivity of toroidal resonances to the 
environmental perturbations enabled to devise a metasensor platform with unique LoD down to ~4.2 fmol. 
The performance of the plasmonic sensor device was carefully analyzed in highly diluted solutions 
containing BSA biomolecules and spike protein. This set of studies proved that the proposed metasensor 
can be utilized in the detection of SARS-CoV-2 spike proteins in real assays with fairly short sample-to-
result duration (~80 min). We envision that the proposed non-invasive, non-contact, and rapid modality in 
this work allows for the diagnosis of SARS-CoV-2 spike protein at very early-stages with high precision. 
 
Outlook. Our developed on-chip and miniaturized SARS-CoV-2 immunosensor based on THz plasmonic 
toroidal metasurface is able to detect SARS-CoV-2 spike protein selectively at fmol densities. Such of 
sensitive system is required for the early-stage COVID-19 infection diagnostics, assessment of therapy 
efficacy and generating data with it clinical relevance to manage/understand epidemic. Beyond that, 
development of POC system to make COVID-19 diagnosis easy at every location will certainly be useful 
to manage the infection related diseases. The developed metasensor device exhibited excellent performance 
in comparison to reported similar investigations in literature as summarized in Table 1. In future, our aim 
is to detect SARS-CoV-2 spike protein at POC after optimizing all the device components i.e., sensing chip 
(presented in this manuscript), full integration of metachip with microfluidic channel (in progress), and 
ultimately interfacing of analytical unit with smart display system (in progress). Ultimately sensing 
COVID-19 using smartphone based operation. However, the studied and presented sensor device is not yet 
tested using real samples due to lack of administrative formalities. Serious efforts are being made to 
establish a collaboration with U.S. based and overseas hospitals to arrange bio-fluids of COVID-19 infected 
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patient. The results of the complete future studies related with POC sensing of COVID19 based on 
plasmonic and photonic metasensors will be published elsewhere. 
Acknowledgment 
P. M. acknowledges the Start-up research grant (SRG/2019/000330) from Science & Engineering Research 
Board (SERB)-DST, Government of India. 
Authors’ contributions 
A.A. and B.G. equality contributed, and all other authors contributed extensively to the work 
presented in this article. 
Conflicts of interest 
There are no conflicts of interest to declare. 
Data availability 
All reagents used in this manuscript are available from commercial sources. In addition, the data that 
support the plots within this paper and other findings of this study are available from the corresponding 
author upon reasonable request. 
Code availability 
The written and employed custom codes in FDTD program utilized in this study are available from the 
corresponding author upon reasonable request. 
 
 
16 
 
References 
1. C. Wang, P. W. Horby, F. G. Hayden, and G. F. Gao, A novel coronavirus outbreak of global health 
concern. Lancet 395(10223), 470-473 (2020). 
2. Y. –T. Xiang, Y. Yang, W. Li, L. Zhang, Q. Zhang, T. Cheung, and C. H. Ng, Timely mental health 
care for the 2019 novel coronavirus outbreak is urgently needed. Lancet Psychiatry 7(3), 228-229 
(2020). 
3. J. P. Broughton, X. Deng, G. Yu, C. L. Fasching, V. Servellita, J. Singh, X. Miao, J. A. Streithorst, 
A. Granados, A. Sotomayor-Gonzalez, and K. Zorn, CRISPR–Cas12-based detection of SARS-CoV-
2. Nat. Biotechnol. In press (2020). DOI: 10.1038/s41587-020-0513-4. 
4. A. Kaushik, S. Tiwari, R. D. Jayant, A. Marty, and M. Nair, Towards detection and diagnosis of 
Ebola virus disease at point-of-care. Biosens. Bioelectron. 75, 254-272 (2016). 
5. A. Kaushik, S. Tiwari, R. D. Jayant, A. Vashist, R. Nikkhah-Moshaie, N. El-Hage, and M. Nair, 
Electrochemical biosensors for early stage Zika diagnostics. Trends Biotechnol. 35(4), 308-317 
(2017). 
6. A. Kaushik, A. Yndart, S. Kumar, R. D. Jayant, A. Vashist, A. N. Brown, C. –Z. Li, and M. Nair, 
A sensitive electrochemical immunosensor for label-free detection of Zika-virus protein. Sci. Rep. 8, 
9700 (2018). 
7. D. Cucinotta, and M. Vanelli, WHO declares COVID-19 a pandemic, Acta Bio-Medica: Atenei 
Parmensis 91(1), 157-160 (2020). 
8. M. A. Shereen, S. Khan, A. Kazmi, N. Bashir, and R. Siddique, COVID-19 infection: origin, 
transmission, and characteristics of human coronaviruses. J. Adv. Res. 24, 91-98 (2020). 
9. Pan, Yang, Daitao Zhang, Peng Yang, Leo LM Poon, and Quanyi Wang. Viral load of SARS-CoV-
2 in clinical samples, Lancet Infect. Dis. 20(4), 411-412 (2020). 
17 
 
10. Y. Li, L. Yao, J. Li, L. Chen, Y. Song, Z. Cai, and C. Yang, Stability Issues of RT‐PCR Testing 
of SARS‐CoV‐2 for Hospitalized Patients Clinically Diagnosed with COVID‐19, J. Med. Virology In 
press (2020). DOI: 10.1002/jmv.25786. 
11. E. R. Adams, R. Anand, M. I. Andersson, K. Auckland, J. K. Baillie, E. Barnes, J. B. et al. 
Evaluation of antibody testing for SARS-Cov-2 using ELISA and lateral flow immunoassays, medRxiv 
(2020). DOI: 10.1101/2020.04.15.20066407. 
12. T. Nguyen, D. D. Bang, and A. Wolff, 2019 novel coronavirus disease (COVID-19): paving the 
road for rapid detection and point-of-care diagnostics. Micromachines 11(3), 306 (2020). 
13. B. Visseaux, Q. Le Hingrat, G. Collin, D. Bouzid, S. Lebourgeois, D. Le Pluart, L. Deconinck et 
al. Evaluation of the QIAstat-Dx Respiratory SARS-CoV-2 Panel, the first rapid multiplex PCR 
commercial assay for SARS-CoV-2 detection, J. Clinic. Microbiol. In press (2020). DOI: 
10.1128/JCM.00630-20. 
14. Y. Fang, H. Zhang, J. Xie, M. Lin, L. Ying, P. Pang, and W. Ji, Sensitivity of chest CT for 
COVID-19: comparison to RT-PCR. Radiology In press 200432 (2020). DOI: 
10.1148/radiol.2020200432. 
15. Y. –W. Tang, J. E. Schmitz, D. H. Persing, and C. W. Stratton, The laboratory diagnosis of 
COVID-19 infection: current issues and challenges. J. Clinic. Microbial. In press (2020). DOI: 
10.1128/JCM.00512-20. 
16. R. Sabino-Silva, A. C. Gomes Jardim, and W. L. Siqueira. Coronavirus COVID-19 impacts to 
dentistry and potential salivary diagnosis, Clinic, Oral Investigations 24, 1619–1621 (2020). 
17. L. Azzi, G. Carcano, F. Gianfagna, P. Grossi, D. D. Gasperina, A. Genoni, M. Fasano et al. Saliva 
is a reliable tool to detect SARS-CoV-2. J. Infection In press (2020). DOI: 10.1016/j.jinf.2020.04.005. 
18. G. Qiu, Guangyu, Z. Gai, Y. Tao, J. Schmitt, G. A. Kullak-Ublick, and J. Wang, Dual-functional 
plasmonic photothermal biosensors for highly accurate severe acute respiratory syndrome coronavirus 
2 detection. ACS Nano In press (2020). DOI: 10.1021/acsnano.0c02439. 
18 
 
19. Z. Chen, Z. Zhang, X. Zhai, Y. Li, L. Lin, H. Zhao, L. Bian, Peng Li, Lei Yu, Yingsong Wu, and 
Guanfeng Lin, Rapid and sensitive detection of anti-SARS-CoV-2 IgG using lanthanide-doped 
nanoparticles-based lateral flow immunoassay. Anal. Chem. In Press (2020). DOI: 
10.1021/acs.analchem.0c00784. 
20. G. Seo, G. Lee, M. J. Kim, S. –H. Baek, M. Choi, K. B. Ku, C. –S. Lee, S. Jun, D. Park, H. G. 
Kim, and S. J. Kim, Rapid detection of COVID-19 causative virus (SARS-CoV-2) in human 
nasopharyngeal swab specimens using field-effect transistor-based biosensor. ACS Nano 14(4), 5135-
5142 (2020). 
21. T. Sannomiya, O. Scholder, K. Jefimovs, C. Hafner, and A. B. Dahlin, Investigation of 
plasmon resonances in metal films with nanohole arrays for biosensing applications, Small 7(12), 
1653-1663 (2011). 
22. S. Zhang, R. Geryak, J. Geldmeier, S. Kim, V. V. Tsukruk, Synthesis, assembly, and 
applications of hybrid nanostructures for biosensing. Chem. Rev. 117, 12942-13038 (2017). 
23. S. Zeng, K. V. Sreekanth, J. Shang, T. Yu, C. K. Chen, F. Yin, D. Baillargeat, P. Coquet, H. 
P. Ho, A. V. Kabashin, and K. T. Yong, Graphene–gold metasurface architectures for ultrasensitive 
plasmonic biosensing. Adv. Mater. 27(40), 6163-6169 (2015). 
24. F. A. A. Nugroho, D. Albinsson, T. J. Antosiewicz, and C. Langhammer, C. Plasmonic 
metasurface for spatially resolved optical sensing in three dimensions. ACS Nano, 14(2), 2345-2353 
(2020). 
25. M. E. Stewart, C. R. Anderton, L. B. Thompson, J. Maria, S. K. Gray, J. A. Rogers, and R. G. 
Nuzzo, Nanostructured plasmonic sensor. Chem. Rev. 108(2), 494-521 (2008). 
26. A. V. Kabashin, P. Evans, S. Pastkovsky, W. Hendren, G. A. Wurtz, R. Atkinson, R. Pollard, 
V. A. Podolskiy, and A. V. Zayats, Plasmonic nanorod metamaterials for biosensing. Nat. Mater. 
8(11), 867-871 (2009). 
27. A. G. Brolo, Plasmonics for future biosensors, Nat. Photonics 6(11), 709-713 (2012). 
19 
 
28. P. Wang, M. E. Nasir, A. V. Krasavin, W. Dickson, Y. Jiang, and A. V. Zayats, Plasmonic 
metamaterials for nanochemistry and sensing. Acc. Chem. Res. 52(11), 3018-3028 (2019). 
29. A. Ahmadivand, B. Gerislioglu, R. Ahuja, and Y. K. Mishra, Terahertz plasmonics: The rise 
of toroidal metadevices towards immunobiosensings. Mater. Today 32, 108-130 (2020). 
30. Y. Y. Lee, R. M. Kim, S. W. Im, M. Balamurugan, and K. T. Nam, Plasmonic metamaterials for 
chiral sensing applications. Nanoscale 12(1), 58-66 (2020). 
31. A. Ahmadivand, B. Gerislioglu, P. Manickam, A. Kaushik, S. Bhansali, M. Nair, and N. Pala, 
Rapid detection of infectious envelope proteins by magnetoplasmonic toroidal metasensors, ACS Sens. 
2(9), 1359-1368 (2017). 
32. M. Gupta, Y. Kumar Srivastava, M. Manjappa, and R. Singh, Sensing with toroidal metamaterial, 
Appl. Phys. Lett. 110(12), 121108 (2017). 
33. A. Ahmadivand, B. Gerislioglu, A. Tomitaka, P. Manickam, A. Kaushik, S. Bhansali, M. Nair, 
and N. Pala, Extreme sensitive metasensor for targeted biomarkers identification using colloidal 
nanoparticles-integrated plasmonic unit cells. Biomed. Opt. Express 9(2), 373-386 (2018). 
34. A. Ahmadivand, B. Gerislioglu, Z. Ramezani, and S. A. Ghoreishi, Attomolar detection of low-
molecular weight antibiotics using midinfrared-resonant toroidal plasmonic metachip technology, 
Phys. Rev. Appl. 12(3), 034018 (2019). 
35. A. Ahmadivand, R. Sinha, B. Gerislioglu, and N. Pala, Sensor platform based on toroidal 
resonances for rapid detection of biomolecules. U.S. Patent 10,288,563, (2019). 
36. V. M. Dubovik, and V. V. Tugushev, Toroid moments in electrodynamics and solid-state physics. 
Phys. Rep. 187(4), 145-202 (1990). 
37. V. M. Dubovik, M. A. Martsenyuk, and B. Saha, Material equations for electromagnetism with 
toroidal polarizations. Phys. Rev. E 61(6), 7087 (2000). 
38. Ia. B. Zel'Dovich, Electromagnetic interaction with parity violation. J. Exp. Theor. Phys. 33, 
1531–1533 (1957). 
20 
 
39. Fedotov, V. A., Marinov, K., Boardman, A. D. & Zheludev, N. I. On the aromagnetism and 
anapole moment of anthracene nanocrystals. New J. Phys. 9, 95 (2007). 
40. Kaelberer, T., V. A. Fedotov, N. Papasimakis, D. P. Tsai, and N. I. Zheludev, Toroidal dipolar 
response in a metamaterial, Science 330(6010), 1510-1512 (2010). 
41. N. Papasimakis, V. A. Fedotov, V. Savinov, T. A. Raybould, and N. I. Zheludev. Electromagnetic 
toroidal excitations in matter and free space. Nat. Mater. 15(3), 263-271 (2016). 
42. Z. –G. Dong, P. Ni, J. Zhu, X. Yin, and X. Zhang, Toroidal dipole response in a multifold double-
ring metamaterial. Opt. Express 20(12), 13065-13070 (2012). 
43. B. Gerislioglu, A. Ahmadivand, and J. Adam, Infrared plasmonic photodetectors: the emergence 
of high photon yield toroidal metadevices. Materials Today Chemistry 14, 100206 (2019). 
44. B. Han, X. Li, C. Sui, J. Diao, X. Jing, and Z. Hong, Analog of electromagnetically induced 
transparency in an E-shaped all-dielectric metasurface based on toroidal dipolar response. Opt. Mater. 
Express 8(8), 2197-2207 (2018). 
45. A. Ahmadivand, B. Gerislioglu, and Z. Ramezani, Generation of magnetoelectric photocurrents 
using toroidal resonances: a new class of infrared plasmonic photodetectors. Nanoscale 11(27), 13108-
13116 (2019). 
46. K. V. Sreekanth, Y. Alapan, M. ElKabbash, E. Ilker, M. Hinczewski, U. A. Gurkan, A. De Luca, 
and G. Strangi, Extreme sensitivity biosensing platform based on hyperbolic metamaterials. Nat. 
Mater. 15(6), 621-627 (2016). 
47. M. Gupta, V. Savinov, N. Xu, L. Cong, G. Dayal, S. Wang, W. Zhang, N. I. Zheludev, and R. 
Singh, Sharp toroidal resonances in planar terahertz metasurfaces. Adv. Mater. 28(37), 8206-8211 
(2016). 
48. A. Ahmadivand, B. Gerislioglu, Directional toroidal dipoles driven by oblique poloidal and loop 
current flows in plasmonic meta-atoms. J. Phys. Chem. C 122(42), 24304-24308 (2018). 
21 
 
49. A. Ahmadivand, B. Gerislioglu, G. T. Noe, and Y. Kumar Mishra, Gated graphene enabled 
tunable charge–current configurations in hybrid plasmonic metamaterials. ACS Appl. Electron. Mater. 
1(5), 637-641 (2019). 
50. E. E. Radescu, and G. Vaman, Toroid moments in the momentum and angular momentum loss 
by a radiating arbitrary source. Phys. Rev. E 65(3), 035601 (2003). 
51. A. J. Haes, and R. P. Van Duyne, A unified view of propagating and localized surface plasmon 
resonance biosensors. Anal. Bioanalytical Chem. 379(7-8), 920-930 (2004). 
52. K. M. Mayer, and J. H. Hafner, Localized surface plasmon resonance sensors. Chem. Rev. 111(6), 
3828-3857 (2011). 
53. C. Wu, A. B. Khanikaev, R. Adato, N. Arju, A. A. Yanik, H. Altug, and G. Shvets, Fano-resonant 
asymmetric metamaterials for ultrasensitive spectroscopy and identification of molecular monolayers, 
Nat. Mater. 11(1), 69-75 (2012). 
54. T. Klar, M. Perner, S. Grosse, G. Von Plessen, W. Spirkl, and J. Feldmann, Surface-plasmon 
resonances in single metallic nanoparticles. Phys. Rev. Lett. 80(19), 4249 (1998). 
55. A. Ahmadivand, R. Sinha, B. Gerislioglu, M. Karabiyik, N. Pala, and M. Shur, Transition from 
capacitive coupling to direct charge transfer in asymmetric terahertz plasmonic assemblies. Opt. Lett. 
41(22), 5333-5336 (2016). 
